MET and neoplasm: One such RTK possibly involved in the DDR is MET, the RTK for hepatocyte growth factor (HGF) which is deregulated in abundance and/or activity in a variety of human tumor types (Matsumoto et al., 2017) and serves as an oncogenic target (Peters and Adjei, 2012).